Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - neuromuskulaarisen salpauksen aiheuttama rokuronin tai vekuronin. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
losartan/hydrochlorothiazide teva 50 mg / 12.5 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - hydrochlorothiazidum,losartanum kalicum - tabletti, kalvopäällysteinen - 50 mg / 12.5 mg - losartaani ja diureetit
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
losartan/hydrochlorothiazide teva 100 mg / 25 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - hydrochlorothiazidum,losartanum kalicum - tabletti, kalvopäällysteinen - 100 mg / 25 mg - losartaani ja diureetit
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
roclanda
santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - silmätautien - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
zantac 150 mg tabletti, kalvopäällysteinen
glaxosmithkline (ireland) limited - ranitidini hydrochloridum - tabletti, kalvopäällysteinen - 150 mg - ranitidiini
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
zantac 300 mg tabletti, kalvopäällysteinen
glaxosmithkline (ireland) limited - ranitidini hydrochloridum - tabletti, kalvopäällysteinen - 300 mg - ranitidiini
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
dexametason 1.5 mg tabletti
orion corporation - dexamethasonum - tabletti - 1.5 mg - deksametasoni